Arvinas

US FDA Approves Pfizer, Arvinas Breast Cancer Drug

The US FDA approved Pfizer and Arvinas' breast cancer drug Veppanu for patients with ESR1-mutated advanced disease. Clinical trials demonstrated improved survival over standard therapy, accompanied by